“Graves’ disease Market” has been added to DelveInsight
Graves’ disease Overview
Graves’ disease (GD) is an autoimmune disorder that causes the overproduction of thyroid hormones and consequent cascade of systemic metabolism dysfunction. It may also affect other multiple organs including eyes and skin. It is the most common cause of hyperthyroidism. It results from the stimulation of autoantibodies to the thyrotropin receptor of thyroid follicular cells. It usually occurs between 30 and 50 years of age, but all ages can be affected.
Graves’ disease Market: Forecast
DelveInsight’s “Graves’ Disease – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Graves’ Disease, historical and forecasted epidemiology as well as the Graves’ Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Graves’ disease Market: Report
The Graves’ Disease market report provides current treatment practices, emerging drugs, Graves’ Disease market share of the individual therapies, current and forecasted Graves’ Disease market Size from 2018 to 2030 segmented by seven major markets. The Report also covers current Graves’ Disease treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
Request Free Sample Copy- https://www.delveinsight.com/sample-request/graves-disease-market
Graves’ disease Market: Geography Covered
Graves’ disease Market: Symptoms
Some of the common symptoms are: weight loss, anxiety, restlessness, tremors, irritability, insomnia, heat intolerance, sweating, chest pain, palpitations, shortness of breath, difficulty breathing, increased stool frequency (with or without diarrhea),irregular menstrual periods, muscle weakness etc. Like all autoimmune diseases, it occurs more commonly in patients with a positive family history.
Graves’ disease Market: Disease
The disease is more common in monozygotic twins than in dizygotic twins. It is precipitated by environmental factors like stress, smoking, infection, iodine exposure, and postpartum, as well as after highly active antiretroviral therapy (HAART) due to immune reconstitution. Graves’ Disease is more common in women as compared to men.
Graves’ disease Market: Size
The market size of Graves’ Disease in seven major markets is approximately USD 301.00 million in 2017. United States is expected to grab the highest market share of Graves’ disease market with ~USD 147.9 million in 2017. Among EU5 countries, Germany has the highest market size, with ~USD 26.8 million, while Spain had the lowest market size of Graves’ disease, with ~USD 13.0 million in 2017.
Graves’ disease Market: Emerging Drugs Analysis
From the last five to six decades, the market of Graves’ disease is based on Antithyroid drugs, Radioactive Iodine, and Surgery. Therefore, until now, the market hasshown slow growth. Hitherto, the market consists of various unmet needs which include the necessity of drugs to cure the disease with fewer side effects, and the need for thyroid hormone replacement medication. With continuous efforts in research and development, recently, few companies such as Horizon Pharma, Novartis, Apitope, and Immunovant are developing therapeutic molecules for the treatment of patients with Grave’s Disease and its manifestations GO (Gravis ophthalmopathy).
Table of content
1. Key Insights
2. Executive Summary of Graves’ Disease
3. Competitive Intelligence Analysis for Graves’ Disease
4. Graves’ Disease: Market Overview at a Glance
5. Graves’ Disease: Disease Background and Overview
6. Patient Journey
7. Graves’ Disease Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Graves’ Disease Treatment
11. Marketed Products
12. Emerging Therapies
13. Graves’ Disease: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Graves ‘disease
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Graves ‘disease Market: Report Highlights
Why should you buy this report?
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Yash BhardwajEmail: Send EmailPhone: +919650213330Address:304 S. Jones Blvd #2432 City: Las VegasState: NVCountry: United StatesWebsite: https://www.delveinsight.com/